Hosted on MSN11d
Blood test could guide use of anti-inflammatory drug celecoxib to reduce risk of colon cancer recurrenceThe analysis showed that patients with positive blood tests for circulating tumor DNA (ctDNA) had worse outcomes in general, ...
The lesions, symmetrically distributed on the trunk and upper and lower limbs (Figure 1), appeared 3 hours after the ingestion of 200 mg of celecoxib for cervical pain caused by osteoarthritis.
Celecoxib is a sulfonamide-containing drug and is therefore contraindicated in those patients who have demonstrated allergic reactions to sulfonamides. [1] ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results